Opening Up New Horizons with 3DEXPERIENCE

In the past two decades, R&D costs have increased from $ 250m to $ 1B per drug, while new drug approvals dropped from 200 to 100 per year. Six months after drug patent, a pharmaceutical company may experience up to 80% revenue loss due to competition from generic drugs. In this competitive business environment, Pharmaceutical and Biotech companies must balance speed versus control by improving common enterprise processes and then track and measure those processes as a basis for improvement

Dassault Systemes (DS)’ Product Life Cycle Management (PLM) solution increase business agility by streamlining product development processes to be in line with project goals and market requirements by maintaining the traceability from product ideation to commercialization and obsolescence.  The solution helps companies speed up the compliance process by integrating regulatory requirements into product development process and aiding the e-submission process for drug approval.

In the industry where it is standardization and quality is a matter of utmost importance, PLM helps companies maintain product quality level while driving materials costs down through lean and efficient use of Intellectual Property (IP). Material costs can be driven down by publishing material specifications across brands, regions and categories to create efficient procurement process. Creating a centrally managed global virtual work teams and using a single repository to store all product information throughout their life cycle also enable manufacturing outsourcing.

PLM also help companies better manage their strategic suppliers and partners by bringing them earlier in the development process and by keeping track of their performance level. Having one cohesive solution allowing collaboration, information sharing, and visibility into the complete development process increases innovation, reduces downstream errors and time to market.